Cargando…
Non-Small Cell Lung Cancer (NSCLC) in Young Adults, Age < 50, Is Associated with Late Stage at Presentation and a Very Poor Prognosis in Patients That Do Not Have a Targeted Therapy Option: A Real-World Study
SIMPLE SUMMARY: Non-small cell lung cancer in young adults spans all ethnic backgrounds and is associated with advanced disease and poor outcomes. Identification of genetic changes that are associated with disease and can subsequently be targeted with specific therapies is associated with improved s...
Autores principales: | Hughes, Daniel Johnathan, Kapiris, Matthaios, Podvez Nevajda, Andreja, McGrath, Harriet, Stavraka, Chara, Ahmad, Shahreen, Taylor, Benjamin, Cook, Gary J. R., Ghosh, Sharmistha, Josephs, Debra, Pintus, Elias, Gennatas, Spyridon, Bille, Andrea, Ryanna, Kimuli, Santis, George, Montes, Ana, Van Hemelrijck, Mieke, Karapanagiotou, Eleni, Smith, Daniel, Spicer, James, Georgiou, Alexandros |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776398/ https://www.ncbi.nlm.nih.gov/pubmed/36551542 http://dx.doi.org/10.3390/cancers14246056 |
Ejemplares similares
-
Clinical implementation of pre-treatment DPYD genotyping in capecitabine-treated metastatic breast cancer patients
por: Stavraka, Chara, et al.
Publicado: (2019) -
Macrophages in ovarian cancer and their interactions with monoclonal antibody therapies
por: Osborn, Gabriel, et al.
Publicado: (2021) -
Clinical and Translational Significance of Basophils in Patients with Cancer
por: Chauhan, Jitesh, et al.
Publicado: (2022) -
The La-Related Proteins, a Family with Connections to Cancer
por: Stavraka, Chara, et al.
Publicado: (2015) -
IgE Antibodies against Cancer: Efficacy and Safety
por: Chauhan, Jitesh, et al.
Publicado: (2020)